[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100562959":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":31,"locations":37,"responsibleParty":57,"collaborators":25,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":63,"acronym":25,"eligibilityCriteria":64,"healthyVolunteers":61,"sex":65,"minAge":66,"maxAge":67,"enrollmentInfo":68,"targetDuration":25,"studyType":71,"phases":72,"briefSummary":74,"conditions":75,"keywords":77,"overallStatus":40,"whyStopped":25,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Foundation University Islamabad","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Nostril Breathing along with pharmacological therapy Group","EXPERIMENTAL","Patients in this group will receive alternative nostril breathing along with pharmacological management.\n\nTotal 4 weeks protocol. Two sessions per week will be supervised by physiotherapist and 5 days at home. A home diary will be provided in order to ensure and follow-up that participants are performing breathing exercise at home.",[13,14],"Other: Alternative nostril breathing","Drug: Pharmacological therapy",{"label":16,"type":17,"description":18,"interventionNames":19},"Pharmacological therapy Group","ACTIVE_COMPARATOR","Patients will receive medication as prescribed by pulmonologist through stepwise approach according to symptoms and severity. Total 4 weeks protocol.\n\nBefore and after 4 weeks pre and post interventional values will be taken.",[14],[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Alternative nostril breathing","Patients in this group will receive alternative nostril breathing along with pharmacological management. For alternative nostirl breathing patient will be advised to inhale slowly (4sec) and deeply through left nostril.Then hold breath for 2-3 sec. Release right nostril and use right ring finger to close left nostril. Exhale slowly (6sec) and completely through right nostril. Inhale slowly (4sec) and deeply through right nostril. Then hold breath for 2-3sec. Release left nostril and use right thumb to close right nostril. Exhale slowly (6sec) and completely through left nostril. Repeat the cycle.",[9],null,{"type":27,"name":28,"description":29,"armGroupLabels":30,"otherNames":25},"DRUG","Pharmacological therapy","Participants in this group will only be provided with standard pharmacological management for 4 weeks as prescribed by a pulmonologist. For example:\n\nSalbutamol inhaler (Short acting bronchodilator) Saltra inhaler (Selective long acting β2 adrenoceptor agonist) Tiotropium (Anticholinergic) Combivir (Nucleoside analogue - reverse transcriptase inhibitor) etc.\n\nWeek 01 and week 02:\n\nPatients will receive medication prescribed by pulmonologist.\n\nWeek 03 and week 04:\n\nPatients will receive medication prescribed by pulmonologist.",[9,16],[32],{"name":33,"role":34,"phone":35,"phoneExt":25,"email":36},"Bazkha Tariq Aslam Khawaja, DPT","CONTACT","0333-1281293","bazkhatariq@gmail.com",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Foundation University College of Physical Therapy","RECRUITING","Rawalpindi","Punjab Province","46000","Pakistan","PK",{"type":47,"coordinates":48},"Point",[49,50],73.0479,33.59733,{"lat":50,"lon":49},[53],{"name":54,"role":34,"phone":55,"phoneExt":25,"email":56},"Zara Khalid, DPT, MS-CPPT,PHD","0333-5415822","zara.khalid@fui.edu.pk",{"type":58,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR","100562959","additive-effects-of-alternative-nostril-breathing-with-pharmacological-management-on-dyspnea-and-control-pause-in-patients-with-bronchial-asthma-100562959",false,"NCT06609941","Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma","Inclusion Criteria:\n\n* Adults: aged (18-45 years)\n* Gender: Both males and females\n* Grade1- Grade 4 on Modified MRC dyspnea scale\n* Asthma severity classes (intermediate, mild persistent and moderate persistent asthma) acc. to NAEPP national asthma education and prevention program guidlin\n\nExclusion Criteria:\n\n* Patients having acute exacerbation of COPD or status asthmaticus\n* Patients diagnosed with acute infections\n* Patients unable to follow command\u002F instructions\n* Asthma patients with \\>40 sec control pause duration\n* Patients who fall in red zone of asthma action plan (PEFR \\\u003C 50%)","ALL","18 Years","45 Years",{"count":69,"type":70},32,"ESTIMATED","INTERVENTIONAL",[73],"NA","Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways, leading to repeateted episodes of breathlessness, wheezing and labored breathing.Breathing exercises help to manage hyperventilation often seen in asthmatic patients. To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications.",[76],"Bronchial Asthma",[78],"Dyspnea, asthma control, peak expiratory flow rate","2024-09-20",{"date":81,"type":82},"2024-09-24","ACTUAL",{"date":84,"type":82},"2024-06-18",{"date":86,"type":70},"2025-02-01",{"name":5,"class":6},1]